Experienced in Chronic Obstructive Pulmonary Disease (COPD)

Christian Karagiannidis

Koeln, NW, DE 
Experienced in Chronic Obstructive Pulmonary Disease (COPD)
Koeln, NW, DE 
OverviewLocationsClinical Research

Overview

Christian Karagiannidis practices in Koeln, Germany. Mr. Karagiannidis is rated as an Experienced expert by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Respiratory Acidosis, Acute Respiratory Distress Syndrome (ARDS), Severe Acute Respiratory Syndrome (SARS), and COVID-19.

His clinical research consists of co-authoring 121 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles and participated in 1 clinical trial in the study of Chronic Obstructive Pulmonary Disease (COPD).

Gender
Male

Locations

Koeln, NW, Germany
Other Locations
Witten, NW, Germany
Herdecke, NW, Germany
Berlin, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicentre, Randomized-controlled Trial of EXtracorporeal CO2 Removal to Facilitate Early Extubation Compared to Invasive Mechanical Ventilation in Patients with Severe Acute Exacerbation of COPD (X-COPD)
A Multicentre, Randomized-controlled Trial of EXtracorporeal CO2 Removal to Facilitate Early Extubation Compared to Invasive Mechanical Ventilation in Patients with Severe Acute Exacerbation of COPD (X-COPD)
Enrollment Status: Terminated
Publish Date: March 14, 2025
Intervention Type: Device, Other
Study Phase: Not Applicable
A Randomized, Controlled, Multicenter, Parallel-Group Phase IIa Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of Severe COVID-19
A Randomized, Controlled, Multicenter, Parallel-Group Phase IIa Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of Severe COVID-19
Enrollment Status: Terminated
Publish Date: August 29, 2024
Intervention Type: Biological
Study Drug: Allogeneic Mesenchymal Stem Cells (MSC)
Study Phase: Phase 2
View 1 Less Clinical Trial

121 Total Publications

Patients should not routinely be treated with ECMO in "peripheral" hospitals
Patients should not routinely be treated with ECMO in "peripheral" hospitals
Journal: Medizinische Klinik, Intensivmedizin und Notfallmedizin
Published: August 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Karagiannidis's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile